Skip to main content
. 2024 Nov 27;15:1483876. doi: 10.3389/fneur.2024.1483876

Table 3.

Total TEAE by severity.

Oxaloacetate (N = 42) Control (N = 40)
Total number of TEAEs 41 40
Number (%) of participants reporting at least one
TEAE 22 (52.4%) 16 (40.0%)
Serious TEAE 0 3 (7.5%)
Related TEAE 12 (28.6%) 7 (17.5%)
Maximum severity
Mild 10 (23.8%) 5 (12.5%)
Moderate 11 (26.2%) 5 (12.5%)
Severe 2 (4.8%) 6 (15.0%)